Salvage high-dose-rate brachytherapy for local recurrence of prostate cancer
https://doi.org/10.17650/1726-9776-2018-14-2-171-175
Abstract
The article describes a successful experience of using high-dose rate brachytherapy (192Ir) in patients with local recurrence of hormone-resistant prostate cancer. High-dose rate brachytherapy allowed to achieve local biochemical control of prostate cancer without toxicity to pelvic organs, thus, maintaining the quality of life.
About the Authors
D. M. Yagudaev
Peoples’ Friendship University of Russia;
N.A. Semashko Central Clinical Hospital No. 2, Russian Railways Company
Russian Federation
Russian Federation
Department of Endoscopic Urology, Faculty of Postgraduate Medical Education RUDN
21/3 Miklukho-Maklaya St., Moscow 117198
Z. A. Kadyrov
Peoples’ Friendship University of Russia
Russian Federation
Russian Federation
Department of Endoscopic Urology, Faculty of Postgraduate Medical Education RUDN
21/3 Miklukho-Maklaya St., Moscow 117198
M. R. Kalinin
N.A. Semashko Central Clinical Hospital No. 2, Russian Railways Company
Russian Federation
2 Budayskaya St., Moscow 129128
Russian Federation
2 Budayskaya St., Moscow 129128
V. A. Bezhenar
N.A. Semashko Central Clinical Hospital No. 2, Russian Railways Company
Russian Federation
2 Budayskaya St., Moscow 129128
Russian Federation
2 Budayskaya St., Moscow 129128
N. A. Kalyagina
A.M. Prokhorov General Physics Institute, Russian Academy of Sciences
Russian Federation
38 Vavilova St., Moscow 119991
Russian Federation
38 Vavilova St., Moscow 119991
References
1. Siegel R., Ma J., Zou Z., Jemal A. Cancer statistics, 2014. C A Cancer J Clin 2014;64:9–29. DOI: 10.3322/caac.21208. PMID: 24399786.
2. Jung K.W., Won Y.J., Kong H.J. et al. Cancer statistics in Korea: incidence, mortality, survival and prevalence in 2010. Cancer Res Treat 2013;45(1):1–14. DOI: 10.4143/crt.2013.45.1.1. PMID: 23613665.
3. Scher H.I., Halabi S., Tannock I. et al. Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the Prostate Cancer Clinical Trials Working Group. J Clin Oncol 2008;26(7):1148–59. DOI: 10.1200/JCO.2007.12.4487. PMID: 18309951.
4. Huggins C., Hodges C.V. Studies on prostatic cancer: I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. Cancer Res 1941;1:293–7. [Reprinted in: J Urol 2002;168(1):9–12. PMID: 12050481.]
5. Luo J., Beer T.M., Graff J.N. Treatment of nonmetastatic castration-resistant prostate cancer. Oncology 2016;30(4):336–44. PMID: 27085332.
6. Moul J.W., Banez L.L., Freedland S.J. Rising PSA in nonmetastatic prostate cancer. Oncology 2007;21(12):1436–45. PMID: 18077992.
7. Nguyen P.L., Chen M.H., D’Amico A.V. et al. Magnetic resonance image-guided salvage brachytherapy after radiation in select men who initially presented with favorable-risk prostate cancer: a prospective phase 2 study. Cancer 2007;110(7):1485–92. DOI: 10.1002/cncr.22934. PMID: 17701957.
8. De Cicco L., Vavassori A., Cattani F. et al. Salvage high dose rate brachytherapy after primary external beam irradiation in localized prostate cancer: a case report. Tumori 2009;95(4):553–6. PMID: 19856677.
9. Pisters L.L., Rewcastle J.C., Donnelly B.J. et al. Salvage prostate cryoablation: initial results from the cryo on-line data registry. J Urol 2008;180(2):559–63. DOI: 10.1016/j.juro.2008.04.005. PMID: 18554664.
10. Chalasani V., Martinez C.H., Lim D., Chin J. Salvage HIFU for recurrent prostate cancer after radiotherapy. Prostate Cancer Prostatic Dis 2009;12(2):124–9. DOI: 10.1038/pcan.2008.53. PMID: 18852702.
11. Solodkiy V.A., Pavlov A.Yu., Tsybul’skiy A.D. Salvage high-dose-rate brachytherapy for local prostate cancer recurrence after radical radiotherapy. Onkourologiya = Cancer Urology 2016;12(4):81–6. (In Russ.). DOI: 10.17650/1726-9776-2016-12-4-81-86.
12. Grado G.L., Collins J.M., Kriegshauser J.S. et al. Salvage brachytherapy for localized prostate cancer after radiotherapy failure. Urology 1999;53(1):2–10. PMID: 9886580.
13. Kaljouw E., Pieters B.R., Kovács G., Hoskin P.J. A Delphi consensus study on salvage brachytherapy for prostate cancer relapse after radiotherapy, a Uro-GEC study. Radiother Oncol 2016;118(1):122–30. DOI: 10.1016/j.radonc.2015.10.021. PMID: 26549865.
Review
For citations:
Yagudaev D.M., Kadyrov Z.A., Kalinin M.R., Bezhenar V.A., Kalyagina N.A. Salvage high-dose-rate brachytherapy for local recurrence of prostate cancer. Cancer Urology. 2018;14(2):171-175. (In Russ.) https://doi.org/10.17650/1726-9776-2018-14-2-171-175
Views:
1578
Email this article 